2026– date –
-
Eli Lilly’s Foundayo® (Orforglipron) Receives FDA Approval as First Oral Non-Peptide GLP-1 Receptor Agonist, Demonstrates Significant Weight Loss and Cardiometabolic Improvement
Obesity Medicine Review Unknown Overview Eli Lilly's Orforglipron, branded as Foundayo®, has received FDA approval as the latest oral GLP-1 receptor agonist. Distinguishing itself from oral semaglutide (Wegovy®) as a small-molecule, non-... -
Ivonescimab Significantly Improves Overall Survival vs. Pembrolizumab in First-Line PD-L1 Positive Advanced NSCLC
The ASCO Post Unknown Overview Ivonescimab, a first-in-class PD-1/VEGF bispecific antibody, demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to pembrolizumab as a first-line... -
BioNTech Announces gotistobart Phase III Achieves Median OS of 18.5 Months in Squamous NSCLC at WCLC 2026
european biotechnology Germany Overview At the World Conference on Lung Cancer (WCLC) 2026 in Seoul, BioNTech presented pivotal data from the Phase III PRESERVE-003 trial for gotistobart (BNT316/ONC-392), a pH-sensitive anti-CTLA-4 antib... -
Novel Bispecific ADC ICP-B381, Targeting PSMA and STEAP1, Approved for Phase 1 Clinical Trials in China for Prostate Cancer; US IND Submission Underway
Prostate Warriors China Overview ICP-B381, a novel bispecific antibody-drug conjugate (ADC) designed to simultaneously target PSMA and STEAP1, has received approval from Chinese regulatory authorities to commence Phase 1 clinical trials ... -
Gan & Lee Pharmaceuticals Initiates Phase I Trial for Once-Weekly Oral GLP-1 Peptide GZC8072 in China, Targeting Obesity and Type 2 Diabetes
AllSci China Overview Gan & Lee Pharmaceuticals Co., Ltd. has commenced its Phase I clinical trial for GZC8072, a novel once-weekly oral GLP-1 receptor peptide agonist, targeting type 2 diabetes and weight management in overweight or... -
Yuedong New Energy Accelerates Over RMB 12.5 Billion Project for 5 GWh/Year Semi-Solid Battery PACK Energy Storage Container Production
Energytrend China Overview Yuedong New Energy Technology (Zhejiang) Co., Ltd. is pushing forward with a large-scale project exceeding RMB 12.5 billion (approximately $1.75 billion USD) to produce and sell lithium-ion battery module assem... -
QuantumScape to Double Pilot Line Production by Year-End, Scaling Anode-Free Solid-State Battery Output for Expanding Market
MarketBeat USA Overview QuantumScape announced plans to double its pilot line production by year-end compared to Q2 2026, driven by internal operational improvements, enhanced equipment utilization, improved yields, and process maturity.... -
German-US Collaboration Unlocks Microscopic Origins of Dendrite Formation in Solid-State Batteries via Comprehensive Review
AZoM Germany Overview A collaborative research team from Forschungszentrum Jülich, RWTH Aachen University (Germany), and Stanford University (USA) published a comprehensive review in eScience journal on the microscopic origins of dendrit... -
Samsung SDI to Invest ₩16 Trillion in Ulsan for 2027 Solid-State Battery Mass Production, Achieving 900 Wh/L with Silver-Carbon Anode-Free Design
Multiple sources cited in snippet South Korea Overview Samsung SDI announced a ₩16 trillion investment in its Ulsan plant, targeting mass production of all-solid-state batteries (ASB) by 2027. The company's ASB utilizes a sulfide-based s... -
China’s 15th Five-Year Plan Accelerates Solid-State Battery Industrialization; Chery Targets 2027 Vehicle Validation, Tinci Materials Operates 100-Ton Pilot Line
Shanghai Metals Market (SMM) News China Overview China's Ministry of Industry and Information Technology (MIIT) and National Development and Reform Commission (NDRC) announced explicit support for solid-state battery industrialization wi...
